Stocktwits on Twitter: "Puma Biotechnology is tanking after-hours, down over -30% on the likelihood it won't get approval from European agency for its cancer drug. https://t.co/To0cg7EEgW $PBYI… https://t.co/AzItQ6mq2R"
pbyi stocktwits off 56% - www.ncccc.gov.eg
wtzou on LonosEscape
The Gapster (@BuyTheGap) | Stocktwits
StockTwits June 2017 Power Rankings: 10 Stocks You Have To Watch | by Stocktwits, Inc. | The Stocktwits Blog
The Gapster (@BuyTheGap) | Stocktwits
StockTwits June 2017 Power Rankings: 10 Stocks You Have To Watch | by Stocktwits, Inc. | The Stocktwits Blog
Puma Biotechnology to Present at J. P. Morgan Healthcare Conference
StockTwits Trending Alert: Trading recent interest in REVLON